Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Orchard Venture Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$18M
Portfolio companies 6
Rounds per year 0.42
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 2
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Life Science
  • Pharmaceutical
Summary

Orchard Venture Partners appeared to be the Corporate Investor, which was created in 2004. The main office of represented Corporate Investor is situated in the Chicago. The venture was found in North America in United States.

Among the various public portfolio startups of the fund, we may underline Logical Therapeutics, Nymirum, Kereos The fund has exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Health Care, Medical.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Orchard Venture Partners, startups are often financed by Venture Investors, Triathlon Medical Venture Partners, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are Triathlon Medical Venture Partners, Venture Investors, Novartis Venture Fund. In the next rounds fund is usually obtained by Venture Investors, Triathlon Medical Venture Partners, Novo Holdings.

The top activity for fund was in 2005. This Orchard Venture Partners works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Orchard Venture Partners:
Typical Co-investors
Orchard Venture Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Orchard Venture Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Armory Capital Champaign, Illinois, United States
BMNT California, Palo Alto, United States
CCB Principal Asset Management Beijing, Beijing, China
Esfin Gestion Courbevoie, France, Ile-de-France
Goodworks Ventures Missoula, Montana, United States
Groupe Aeroplan Canada, Montreal, Quebec
Heidelpay Baden-Wurttemberg, Germany, Heidelberg
Macnica Ventures -
METRO GROUP Düsseldorf, Germany, Nordrhein-Westfalen
Network Society Ventures New York, New York, United States
OBI SA -
QVC Pennsylvania, United States, West Chester
Seastar China, Dalian Shi, Liaoning
Semantic Ventures England, London, United Kingdom
SK Hynix Seoul, Seoul-t'ukpyolsi, South Korea
Startupbootcamp Smart Transportation & Energy Berlin Berlin, Berlin, Germany
Terrapin Bale Venture Fund & Studio Stockholm, Stockholm County, Sweden
THine Electronics Japan, Tokyo
Venture One New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

GuideCX, Inc.

Consulting
Consumer Software
Information Technology
Internet
Project Management
Software
$10M12 Nov 2020 Utah, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$41M04 Jun 2013 Cambridge, Massachusetts, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$22M26 Apr 2011 Cambridge, Massachusetts, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$25M28 Jul 2009 Cambridge, Massachusetts, United States

Logical Therapeutics

Biotechnology
Health Care
Medical
$30M13 Jun 2007 Massachusetts, United States

Kereos

Biotechnology
Health Care
Life Science
Therapeutics
$19M20 Sep 2005 City of Saint Louis, Missouri, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Orchard Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 18M
Rounds per year 0.42
Peak activity year 2005
Lead investments 0
Follow on index 0.25
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

GuideCX, Inc.

Consulting
Consumer Software
Information Technology
Internet
Project Management
Software
$10M12 Nov 2020 Utah, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$41M04 Jun 2013 Cambridge, Massachusetts, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$22M26 Apr 2011 Cambridge, Massachusetts, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$25M28 Jul 2009 Cambridge, Massachusetts, United States

Logical Therapeutics

Biotechnology
Health Care
Medical
$30M13 Jun 2007 Massachusetts, United States

Kereos

Biotechnology
Health Care
Life Science
Therapeutics
$19M20 Sep 2005 City of Saint Louis, Missouri, United States
Crunchbase icon

Content report

The following text will be sent to our editors: